Malaria News and Research

Latest Malaria News and Research

GenVec completes initial milestone in collaboration with Novartis

GenVec, Inc. today announced that it has achieved the first milestone in its collaboration with Novartis, related to the development of treatments for hearing loss and balance disorders. The milestone was triggered by the successful completion of certain preclinical development activities.

14 Sep 2010

Experts to announce new findings on Malaria control

Leading malaria experts, officials and advocates to announce new findings detailed in "Saving Lives with Malaria Control: Counting Down to the Millennium Development Goals," a report published as part of the Roll Back Malaria Partnership's Progress & Impact Series.

14 Sep 2010

Seattle Times examines how Gates Foundation's goal to eradicate malaria is affecting research

The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.

14 Sep 2010

AIDS advocates call for African Governments to spend more of their own funds on health

Doctors and AIDS activists on Friday urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS.

14 Sep 2010

Inovio Pharmaceuticals achieves promising results in VGX-3100 Phase I study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in its Phase I dose escalation study of VGX-3100, its DNA vaccine to treat pre-cancerous cervical dysplasias and cervical cancers caused by human papillomavirus (HPV) types 16 and 18.

13 Sep 2010

Accord reached on draft declaration for MDG summit

World powers have reached an accord, after weeks of tough talks, on a document to be adopted at a Millennium Development summit this month for which [U.N.] Secretary General Ban Ki-moon is seeking billions of dollars of new funding,Agence France-Presse reports in an article that describes how representatives from donor and developing nations debated how best to pay for a kick start to the ambitious development goals first set at the Millennium summit in 2000.

13 Sep 2010

395 new vaccines being developed for infectious diseases: PhRMA

Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.

10 Sep 2010

Summit negotiators seek to get MDGs 'back on track'

"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.

10 Sep 2010

Opinions: U.S. commitment to Global Fund; Innovative financing; Global food security; Aid for Pakistan

A Times of Trenton editorial looks at the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is "estimated to have already saved 5 million lives, enables programs that prevent and treat infections, eliminate the transmission of HIV from pregnant women to their unborn children, contain the threat of multidrug-resistant TB, and eliminate malaria as a public health problem."

9 Sep 2010

Flood victims in Pakistan helped by Australian health team

Hundreds of Pakistani flood victims have been treated at an Australian health centre set up in the country last week. This center at the Punjab city of Kot Addu is manned by a team of doctors, nurses and paramedics from the Northern Territory, Western Australia, Victoria and Queensland.

8 Sep 2010

Global Fund investigates allegations that donated malaria drugs were stolen, resold in some African countries

After recent research found that some donated malaria drugs are being stolen and sold commercially in several African countries, the Global Fund to Fight AIDS, Tuberculosis and Malaria Communications Director Joe Liden said the group is looking into the situation "in a number of countries," PBS' NewsHour's blog, "The Rundown" reports.

8 Sep 2010

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science, Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials, backed by Swiss pharmaceutical giant Novartis AG, could begin later this year," the Wall Street Journal writes (Naik, 9/3).

4 Sep 2010

VOA News examines U.S. Global Health Initiative

VOA News examines President Barack Obama's $63 billion Global Health Initiative (GHI), noting the initiative's emphasis on cost-effective strategies to improve child- and maternal-health as well as programs to fight HIV/AIDS, tuberculosis (TB) and malaria. The article includes recent comments by Secretary of State Hillary Rodham Clinton on the role the GHI will play in strengthening health systems and the administration's on-going commitment to global HIV/AIDS programs.

4 Sep 2010

IMF, World Bank announce increased aid measures for flood relief in Pakistan

"The IMF and the World Bank have stepped up aid to flood-hit Pakistan to help the country cope with its worst-ever humanitarian disaster," Agence France-Presse reports.

4 Sep 2010

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

UNAIDS Executive Director Michel Sidibe "said Thursday that global contributions to fighting [HIV/AIDS] are dropping off for the first time in 15 years amid tough economic times," Agence France-Presse reports.

3 Sep 2010

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.

3 Sep 2010

Opinions: Pakistan's rebuilding; Kenya's constitution; Development financing; Africa's black market for malaria drugs

A Washington Post editorial encouraging the U.S. to generously support Pakistan as it recovers from major flooding, states: the "humanitarian interest is heightened by Pakistan's centrality to America's national security interests. The Obama administration must seize this chance to deepen and broaden what is already a large commitment, lest Pakistan become even more of a breeding ground for terrorism."

3 Sep 2010

Researchers discover novel compound to combat drug resistant malaria

Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.

3 Sep 2010

Researchers develop new technique to trace counterfeit drugs

Counterfeiting of drugs is a huge industry with an annual turnover of more than SEK 500 billion. In Africa the situation is extremely serious. Half of the malaria medication sold there could be ineffective or even harmful. Researchers from Lund and the UK have now developed a technique that could resolve the situation.

2 Sep 2010

Media examine floods' impact in Pakistan

News outlets reported on the effects of major flooding in Pakistan and described the situation on the ground.

2 Sep 2010

Malaria News and Research

Latest Malaria News and Research

GenVec completes initial milestone in collaboration with Novartis

Experts to announce new findings on Malaria control

Seattle Times examines how Gates Foundation's goal to eradicate malaria is affecting research

AIDS advocates call for African Governments to spend more of their own funds on health

Inovio Pharmaceuticals achieves promising results in VGX-3100 Phase I study

Accord reached on draft declaration for MDG summit

395 new vaccines being developed for infectious diseases: PhRMA

Summit negotiators seek to get MDGs 'back on track'

Opinions: U.S. commitment to Global Fund; Innovative financing; Global food security; Aid for Pakistan

Flood victims in Pakistan helped by Australian health team

Global Fund investigates allegations that donated malaria drugs were stolen, resold in some African countries

Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans

VOA News examines U.S. Global Health Initiative

IMF, World Bank announce increased aid measures for flood relief in Pakistan

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Opinions: Pakistan's rebuilding; Kenya's constitution; Development financing; Africa's black market for malaria drugs

Researchers discover novel compound to combat drug resistant malaria

Researchers develop new technique to trace counterfeit drugs

Media examine floods' impact in Pakistan

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in